Mariamena Arbitrio

7PUBLICATIONS
29CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersMolecular and organic electronicsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2024
Pharmacogenomics: Challenges and Future.

Mariamena Arbitrio

|Feb 24, 2024
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma.

Lydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello

|Jan 23, 2024
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future.

Elzbieta Janda, Jean A Boutin, Carlo De Lorenzo

|Mar 29, 2023
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.

Nicoletta Polerà, Antonia Mancuso, Caterina Riillo

|Jun 24, 2022
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells.

Caterina Riillo, Daniele Caracciolo, Katia Grillone

|May 28, 2022
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics.

Nicoletta Staropoli, Mariamena Arbitrio, Angela Salvino

Pageof 2

Frequent Collaborators

5 joint publications

Pierfrancesco Tassone

4 joint publications

Francesca Scionti

3 joint publications

Maria Teresa Di Martino

2 joint publications

Licia Pensabene